تهیه دارو
Cancer Subtype | Gene | Drug |
Breast Cancer | AKT1 | Capivasertib + Fulvestrant |
BRAF | Dabrafenib + Trametinib | |
ERBB2 | Ado-Trastuzumab Emtansine | |
Lapatinib + Capecitabine, Lapatinib + Letrozole | ||
Margetuximab + Chemotherapy | ||
Neratinib, Neratinib + Capecitabine | ||
Trastuzumab + Pertuzumab + Chemotherapy | ||
Trastuzumab + Tucatinib + Capecitabine | ||
Trastuzumab Deruxtecan | ||
Trastuzumab, Trastuzumab + Chemotherapy | ||
ESR1 | Elacestrant | |
NTRK1 | Entrectinib | |
Larotrectinib | ||
NTRK2 | Entrectinib | |
Larotrectinib | ||
NTRK3 | Entrectinib | |
Larotrectinib | ||
Microsatellite Instability-High (MSI-H) | Pembrolizumab | |
Tumor Mutational Burden-High (TMB-H) | Pembrolizumab | |
PIK3CA | Alpelisib + Fulvestrant | |
Capivasertib + Fulvestrant | ||
PTEN | Capivasertib + Fulvestrant | |
RET | Selpercatinib |